NDC properties for NDC 9 0703-9514
NDC item 00703951401
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-01 |
NDC Item | 00703951401 |
packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703951403
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-03 |
NDC Item | 00703951403 |
packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0703-9514-03) / 10 mL in 1 VIAL, MULTI-DOSE (0703-9514-01) |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703951481
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-81 |
NDC Item | 00703951481 |
packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703951483
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-83 |
NDC Item | 00703951483 |
packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0703-9514-83) / 10 mL in 1 VIAL, MULTI-DOSE (0703-9514-81) |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703951491
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-91 |
NDC Item | 00703951491 |
packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703951493
NDC 9 | 0703-9514 |
---|---|
NDC 10 | 0703-9514-93 |
NDC Item | 00703951493 |
packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0703-9514-93) / 10 mL in 1 VIAL, MULTI-DOSE (0703-9514-91) |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 716880 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-07-11 |
Marketing status | ACTIVE |
NDC item 00703952601
NDC 9 | 0703-9526 |
---|---|
NDC 10 | 0703-9526-01 |
NDC Item | 00703952601 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-9526-01) / 30 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-08-15 |
Marketing status | ACTIVE |
NDC item 00703952681
NDC 9 | 0703-9526 |
---|---|
NDC 10 | 0703-9526-81 |
NDC Item | 00703952681 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-9526-81) / 30 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA073303 |
FDA SPL set id | 716741 |
FDA SPL set id | 813866 |
Labeler | Teva Parenteral Medicines, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-08-15 |
Marketing status | ACTIVE |
NDC item 67457077930
NDC 9 | 67457-779 |
---|---|
NDC 10 | 67457-779-30 |
NDC Item | 67457077930 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (67457-779-30) / 30 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206607 |
FDA SPL set id | 849345 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-06-30 |
Marketing effective time low | 2017-12-31 |
Marketing status | COMPLETED |
NDC item 67457092230
NDC 9 | 67457-922 |
---|---|
NDC 10 | 67457-922-30 |
NDC Item | 67457092230 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (67457-922-30) / 30 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206607 |
FDA SPL set id | 825030 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-03-31 |
Marketing effective time low | 2020-10-12 |
Marketing status | COMPLETED |
NDC item 70069036201
NDC 9 | 70069-362 |
---|---|
NDC 10 | 70069-362-01 |
NDC Item | 70069036201 |
packaging | 10 mL in 1 VIAL |
ANDA | ANDA212231 |
COLORTEXT | YELLOW(Clear, colorless to pale yellow solution) |
Color | C48330 __ |
FDA SPL set id | 723076 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-08-29 |
Marketing status | ACTIVE |
NDC item 70069036210
NDC 9 | 70069-362 |
---|---|
NDC 10 | 70069-362-10 |
NDC Item | 70069036210 |
packaging | 10 VIAL in 1 CARTON (70069-362-10) / 10 mL in 1 VIAL (70069-362-01) |
ANDA | ANDA212231 |
COLORTEXT | YELLOW(Clear, colorless to pale yellow solution) |
Color | C48330 __ |
FDA SPL set id | 723076 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-08-29 |
Marketing status | ACTIVE |
NDC item 70069036301
NDC 9 | 70069-363 |
---|---|
NDC 10 | 70069-363-01 |
NDC Item | 70069036301 |
packaging | 1 VIAL in 1 CARTON (70069-363-01) / 30 mL in 1 VIAL |
ANDA | ANDA212231 |
COLORTEXT | YELLOW(Clear, colorless to pale yellow solution) |
Color | C48330 __ |
FDA SPL set id | 723076 |
Labeler | Somerset Therapeutics, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-08-29 |
Marketing status | ACTIVE |